Acuren [TIC] vs Cintas [CTAS] Detailed Stock Comparison

Acuren Corporation

NYSE
Loading...

Cintas Corporation

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Acuren Corporation wins in 4 metrics, Cintas Corporation wins in 15 metrics, with 0 ties. Cintas Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Acuren Corporation Cintas Corporation Better
P/E Ratio (TTM) 44.48 36.93 Cintas Corporation
Price-to-Book Ratio 0.87 14.59 Acuren Corporation
Debt-to-Equity Ratio 78.57 60.94 Cintas Corporation
PEG Ratio 15.43 3.83 Cintas Corporation
EV/EBITDA 17.13 25.01 Acuren Corporation
Profit Margin (TTM) -5.69% 17.57% Cintas Corporation
Operating Margin (TTM) -2.71% 23.22% Cintas Corporation
EBITDA Margin (TTM) N/A 23.22% N/A
Return on Equity -5.23% 41.30% Cintas Corporation
Return on Assets (TTM) 0.16% 15.94% Cintas Corporation
Free Cash Flow (TTM) $61.26M $1.76B Cintas Corporation
Dividend Yield N/A 1.10% N/A
1-Year Return -24.26% -20.59% Cintas Corporation
Price-to-Sales Ratio (TTM) 1.24 6.34 Acuren Corporation
Enterprise Value $3.20B $72.61B Cintas Corporation
EV/Revenue Ratio 2.09 6.59 Acuren Corporation
Gross Profit Margin (TTM) 35.19% 50.98% Cintas Corporation
Revenue per Share (TTM) $10 $27 Cintas Corporation
Earnings per Share (Diluted) $-0.60 $4.73 Cintas Corporation
Beta (Stock Volatility) 1.17 1.01 Cintas Corporation
Short % of Float 9.45% 3.33% Cintas Corporation

Acuren Corporation vs Cintas Corporation Stock Performance Analysis

Loading Price Chart...

TIC
CTAS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Acuren Corporation1.06%0.59%-4.58%12.50%-17.47%-13.55%
Cintas Corporation-0.87%0.63%3.82%-9.34%-7.28%-5.48%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Acuren Corporation-24.26%-32.86%225.38%-99.93%-99.89%-99.90%
Cintas Corporation-20.59%43.50%98.71%650.13%2,100.75%1,636.75%

Performance & Financial Health Analysis: Acuren Corporation vs Cintas Corporation

MetricTICCTAS
Market Information
Market Cap i$1.91B$71.06B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i2,773,8821,878,162
90 Day Avg. Volume i3,150,3772,537,417
Last Close$8.55$174.74
52 Week Range$6.36 - $14.94$161.16 - $226.75
% from 52W High-42.79%-22.94%
All-Time High$14,700.00 (Jul 03, 2017)$229.24 (Jun 06, 2025)
% from All-Time High-99.94%-23.77%
Growth Metrics
Quarterly Revenue Growth0.94%0.09%
Quarterly Earnings GrowthN/A0.08%
Financial Health
Profit Margin (TTM) i-0.06%0.18%
Operating Margin (TTM) i-0.03%0.23%
Return on Equity (TTM) i-0.05%0.41%
Debt to Equity (MRQ) i78.5760.94
Cash & Liquidity
Book Value per Share (MRQ)$9.84$11.97
Cash per Share (MRQ)$1.98$0.46
Operating Cash Flow (TTM) i$95.02M$2.21B
Levered Free Cash Flow (TTM) i$-30,406,624$1.51B
Dividends
Last 12-Month Dividend Yield iN/A1.10%
Last 12-Month Dividend iN/A$2.13

Valuation & Enterprise Metrics Analysis: Acuren Corporation vs Cintas Corporation

MetricTIC (Apr 26, 2026)CTAS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i44.4836.93
Forward P/E i15.4332.20
PEG Ratio i15.433.83
Price to Sales (TTM) i1.246.34
Price to Book (MRQ) i0.8714.59
Market Capitalization
Market Capitalization i$1.91B$71.06B
Enterprise Value i$3.20B$72.61B
Enterprise Value Metrics
Enterprise to Revenue i2.096.59
Enterprise to EBITDA i17.1325.01
Risk & Other Metrics
Beta i1.171.01
Book Value per Share (MRQ) i$9.84$11.97

Financial Statements Comparison: Acuren Corporation vs Cintas Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTIC (2025)CTAS (2025)
Revenue/Sales i1.53B10.34B
Cost of Goods Sold i1.08B5.17B
COGS % of Revenue i70.6%50.0%
Gross Profit i449.36M5.17B
Gross Margin i29.4%50.0%
Research & Development iN/AN/A
Operating Income (EBIT) i8.53M2.36B
Operating Margin i0.6%22.8%
EBITDA i193.41M2.86B
EBITDA Margin i12.6%27.7%
Pre-Tax Income i-98.17M2.26B
Pre-Tax Income % of Revenue i-6.4%21.9%
Income Tax i-11.06M451.92M
Income Tax % of Revenue i-0.7%4.4%
Net Income (Profit) i-87.12M1.81B
Profit Margin i-5.7%17.5%

Balance Sheet & Liquidity Metrics

MetricTIC (2025)CTAS (2025)
Cash & Equivalents i439.54M263.97M
Total Current Assets i1.02B3.44B
Total Current Assets % of Revenue i66.7%33.2%
Total Current Liabilities i318.99M1.64B
Total Current Liabilities % of Revenue i20.8%15.9%
Long-Term Debt i1.65B2.60B
Long-Term Debt % of Revenue i108.1%25.2%
Total Shareholders Equity i2.18B4.68B
Retained Earnings i-194.11M11.80B
Retained Earnings % of Revenue i-12.7%114.1%
Property, Plant & Equipment i60.21M3.50B

Cash Flow Statement Comparison

MetricTIC (2025)CTAS (2025)
Operating Cash Flow i111.80M2.27B
Operating Cash Flow % of Revenue i7.3%22.0%
Capital Expenditures i-29.07M23.97M
Free Cash Flow i61.26M1.76B
FCF Margin i4.0%17.0%
Debt Repayment i-25.40M-450.00M
Common Stock Repurchase iN/A-934.80M

Short Interest & Institutional Ownership Analysis

MetricTICCTAS
Shares Short i14.41M9.98M
Short Ratio i3.743.80
Short % of Float i9.45%3.33%
Shares Outstanding i220.49M400.02M
Float Shares i107.02M342.08M
% Held by Insiders i8.25%14.97%
% Held by Institutions i85.93%67.80%
% Held by Public i5.82%17.23%

Dividend Analysis & Yield Comparison: Acuren Corporation vs Cintas Corporation

MetricTICCTAS
Last 12-Month Dividend iN/A$2.13
Last 12-Month Dividend Yield iN/A1.10%
3-Year Avg Annual Dividend iN/A$1.62
3-Year Avg Dividend Yield iN/A0.22%
3-Year Total Dividends iN/A$4.85
Ex-Dividend DateN/AFeb 13, 2026